Propranolol attenuates exercise-induced increment in human lymphocytic β-adrenergic receptors

References

• Lefkowitz RJ, Caron MG, Stiles GL. Mechanisms of membrane-receptor regulation. Biochemical, physiological and clinical insights derived from studies of the adrenergic receptors. N Engl J Med 1984; 310: 1570–9
   PubMed Web of Science ®Google Scholar
• Brodde O-E, Kretsch R, Ikezono K, Zerkowski H-R, Reidemeister JC. Human β-adrenoceptors: Relation of myocardial and lymphocyte β-adrenoceptor density. Science 1986; 231: 1584–5
   PubMed Web of Science ®Google Scholar
• Aarons RD, Molinoff PB. Changes in the density of beta adrenergic receptors in rat lymphocytes, heart and lung after chronic treatment with propranolol. J Pharmacol Exp Ther 1982; 221: 439–43
   PubMed Web of Science ®Google Scholar
• Aarons RD, Nies AS, Gal J, Hegstrand LR, Molinoff PB. Elevation of β-adrenergic receptor density in human lymphocytes after propranolol administration. J Clin Invest 1980; 65: 949–57
   PubMed Web of Science ®Google Scholar
• Fraser J, Nadeau J, Robertson D, Wood AJJ. Regulation of human leukocyte beta receptors by endogenous catecholamines. J Clin Invest 1981; 67: 1777–84
   PubMed Web of Science ®Google Scholar
• Piantanelli L, Giunta S, Basso A, Cognini G, Andreoni A, Paciaroni E. Atenolol-induced regulation of leukocyte β2-adrenoceptors in hypertension. Pharmacology 1984; 29: 210–4
   PubMed Web of Science ®Google Scholar
• Hedberg A, Gerber JG, Nies AS, Wolfe BB, Molinoff PB. Effects of pindolol and propranolol on beta adrenergic receptors on human lymphocytes. J Pharmacol Exp Ther 1986; 239: 117–23
   PubMed Web of Science ®Google Scholar
• Butler J, Kelly JG, O'Malley K, Pidgeon F. β-adrenoceptor adaptation to acute exercise. J Physiol 1983; 344: 113–7
   PubMed Web of Science ®Google Scholar
• Burman KD, Ferguson EW, Djuh Y-Y, Wartofsky L, Latham K. Beta receptors in peripheral mononuclear cells increase acutely during exercise. Acta Endocrinol 1985; 109: 563–8
   PubMedGoogle Scholar
• Sable DL, Brammell HL, Sheehan MW, Nies AS, Gerber J, Horwitz LD. Attenuation of exercise conditioning by beta-adrenergic blockade. Circulation 1982; 65: 679–84
   PubMed Web of Science ®Google Scholar
• Mäki T, Kontula K, Myllynen P, Härkönen M. β-adrenergic receptors of human lymphocytes in physically active and immobilized subjects: characterization by a polyethylene glycol precipitation assay. Scand J Clin Lab Invest 1987; 47: 261–7
   PubMed Web of Science ®Google Scholar
• Böyum A. Isolation of mononuclear cells and granulocytes from human blood. Scand J Clin Lab Invest 1968; 21(suppl. 97)77–89
   PubMed Web of Science ®Google Scholar
• Scatchard G. The attraction of proteins for small molecules and ions. Ann Ny Acad Sci 1949; 51: 660–72
   Web of Science ®Google Scholar
• Lowry OH, Rosebrough NY, Farr AL, Randall RY. Protein measurement with the Folin phenol reagent. J Biol Chem 1957; 193: 265–75
   Google Scholar
• Endert E. Determination of noradrenaline and adrenaline in plasma by a radioenzymatic assay using high pressure liquid chromatography for the separation of the radiochemical products. Clin Chim Acta 1979; 96: 233–9
   PubMed Web of Science ®Google Scholar
• Näveri H, Rehunen S, Kuoppasalmi K, Tulikoura I, Härkönen M. Muscle metabolism during and after strenuous intermittent running. Scand J Clin Lab Invest 1978; 38: 329–36
   PubMed Web of Science ®Google Scholar
• Siegel S. Nonparametric statistics for the behavioral sciences. McGraw-Hill Book Company, New York 1956; 75–83
   Google Scholar
• Kobilka BK, Dixon RAF, Frielle T, Dohlman HG, Bolanowski MA, Sigal IS, Yang-Feng TL, Francke U, Caron MG, Lefkowitz RJ. cDNA for the human β-adrenergic receptor: a protein with multiple membrane-spanning domains and encoded by a gene whose chromosomal location is shared with that of the receptor for platelet-derived growth factor. Proc Natl Acad Sci USA 1987; 84: 46–50
   PubMed Web of Science ®Google Scholar
• Goldstein RE, Corash LC, Tallman JF, Lake CR, Hyde J, Smith CC, Capurro NL, Anderson JC. Shortened platelet survival time and enhanced heart rate responses after abrupt withdrawal of propranolol from normal subjects. Am J Cardiol 1981; 47: 1115–22
   PubMed Web of Science ®Google Scholar
• Wahrenberg H, Arner P, Engfeldt P, Haglund K, Rössner S, Östman J. Long-term β1-selective adrenergic blockade and adrenergic receptors in human subcutaneous adipocytes. Acta Med Scand 1985; 217: 539–46
   PubMedGoogle Scholar
• Sklar J, Johnston GD, Overlie P, Gerber JG, Brammell HL, Gal J, Nies AS. The effects of a cardioselective (metoprolol) and a nonselective (propranolol) beta-adrenergic blocker on the response to dynamic exercise in normal men. Circulation 1982; 65: 894–9
   PubMed Web of Science ®Google Scholar
• Morrison SC, Kumana CR, Rudnick KV, Haynes B, Jones NL. Selective and nonselective beta-adrenoceptor blockade in hypertension: responses to changes in posture, cold and exercise. Circulation 1982; 65: 1171–7
   PubMed Web of Science ®Google Scholar
• Tohmeh JF, Cryer PE. Biphasic adrenergic modulation of β-adrenergic receptors in man. Agonist-induced early increment and late decrement in β-adrenergic receptor number. J Clin Invest 1980; 65: 836–40
   PubMed Web of Science ®Google Scholar
• McLeod AA, Brown JE, Kunn C, Kitchell BB, Sedor FA, Williams RS, Shand DG. Differentiation of hemodynamic, humoral and metabolic responses to β1- and β2-adrenergic stimulation in man using atenolol and propranolol. Circulation 1983; 67: 1076–84
   PubMed Web of Science ®Google Scholar
• Lundborg P, Åström H, Bengtsson C, Fellenius E, von Schenck H, Svensson L, Smith U. Effect of β-adrenoceptor blockade on exercise performance and metabolism. Clin Sci 1981; 61: 299–305
   PubMed Web of Science ®Google Scholar